Related Experiment Videos
Case report: Crouzon syndrome with short stature
C R Feild1, A Leiber, C Toniges
1Exceptional Family Member Service, U.S. Army Hospital, Wurzburg, Federal Republic of Germany.
The American Journal of the Medical Sciences
|August 1, 1991
Insights
Children with Crouzon Syndrome may experience partial growth hormone deficiency, impacting growth. Human growth hormone replacement can accelerate growth in these patients.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Growth Disorders
Background:
- Crouzon Syndrome is a genetic disorder characterized by premature fusion of skull bones.
- Craniofacial abnormalities in Crouzon Syndrome can affect overall development.
- Growth disturbances are a potential, though less commonly emphasized, complication.
Observation:
- A five-year-old boy diagnosed with Crouzon Syndrome presented with short stature and delayed bone age.
- Initial assessments indicated partial growth hormone deficiency.
Findings:
- Treatment with human growth hormone (hGH) replacement therapy resulted in accelerated physical growth.
- The patient demonstrated a positive response to hGH therapy, indicating efficacy in addressing the deficiency.
Implications:
- This case highlights the importance of comprehensive growth monitoring in children with Crouzon Syndrome.
- Pediatricians should consider evaluating for growth hormone deficiency in affected children.
- Monitoring all growth parameters, not solely head circumference, is crucial for early detection and intervention.
Abstract:
A five-year-old boy with Crouzon Syndrome, short stature, and delayed bone age was found to have partial growth hormone deficiency. Accelerated growth was observed after human growth hormone replacement. Children with Crouzon Syndrome should be followed closely for all growth parameters, not just head circumference.